Shares of RAPT Therapeutics, Inc. (RAPT) are down more than 9% Friday morning at $19.26.
The company today priced its public offering of 4,054,055 shares at $18.50 per share.
Gross proceeds of $75 million is estimated from the offering, which is expected to close on November 22.
RAPT has traded in the range of $9.85- $40.74 in the last 1 year.
Source: Read Full Article
Lates News:
-
Heritage Insurance Drops 10% After Projecting Catastrophe Losses
-
Bitcoin: A ‘Lottery Ticket’? Ireland’s Central Bank Governor Weighs In on Crypto
-
Bitcoin Could Have Found Its Bottom At $20,000 Level: Glassnode Report
-
Analyst On Why Ethereum Flipping Bitcoin Won't Happen Anytime Soon
-
Crypto Analyst Predicts More Trouble Ahead For Bitcoin Price, Here’s Why